Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Zymeworks Inc. Director's Dealing 2025

Jan 7, 2025

32180_dirs_2025-01-06_ee4e22ea-8fea-46ff-af0e-bd7032a30679.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Zymeworks Inc. (ZYME)
CIK: 0001937653
Period of Report: 2025-01-06

Reporting Person: Galbraith Kenneth (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-01-06 Common Stock M 47666 Acquired 71428 Direct
2025-01-06 Common Stock S 23885 $14.9241 Disposed 47543 Direct
2025-01-06 Common Stock M 66666 Acquired 114209 Direct
2025-01-06 Common Stock S 33406 $14.9241 Disposed 80803 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-01-06 Restricted Stock Unit $ M 47666 Disposed Common Stock (47666) Direct
2025-01-06 Restricted Stock Unit $ M 66666 Disposed Common Stock (66666) Direct

Footnotes

F1: Represents shares of common stock issued upon vesting of one third of the restricted stock units ("RSUs") granted on January 5, 2023.

F2: Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs pursuant to mandatory "sell to cover" provisions contained in the Reporting Person's applicable RSU grant agreement, and does not represent a discretionary sale by the Reporting Person. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.

F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.44 to $15.14, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F4: Represents shares of common stock issued upon vesting of one third of the RSUs granted on January 5, 2024.

F5: Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.

F6: The RSUS were granted on January 5, 2023 and vest in three equal annual installments beginning on the first anniversary of January 5, 2023.

F7: The RSUS were granted on January 5, 2024 and vest in three equal annual installments beginning on the first anniversary of January 5, 2024.